Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Melanoma 1Carcinoma, Merkel Cell 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

pembrolizumab 592Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 508Specimen Handling 504Nivolumab 408Cisplatin 370Carboplatin 359Biopsy 304Blood Specimen Collection 295Radiosurgery 284Paclitaxel 274Surveys and Questionnaires 268Gemcitabine 267Standard of Care 266fludarabine 261Dexamethasone 258Drug Therapy 257venetoclax 247Bevacizumab 246Oxaliplatin 206Rituximab 196Capecitabine 196Radiation 189Fluorouracil 186Ipilimumab 185durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Predictive Learning Models × 1 year × Clear all
NCT03927768 2025-10-30

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

NYU Langone Health

Active not recruiting
264 enrolled
Breast

Breast Neoplasms

NCT06536257 2025-09-18

PIP-PREDICT

Melanoma Institute Australia

Recruiting
1,000 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡